Ignite Creation Date:
2025-12-24 @ 5:03 PM
Ignite Modification Date:
2025-12-29 @ 2:22 PM
Study NCT ID:
NCT04915950
Status:
TERMINATED
Last Update Posted:
2023-12-22
First Post:
2021-06-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-03
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-02
Completion Date Type:
ACTUAL
First Submit Date:
2021-06-01
First Submit QC Date:
None
Study First Post Date:
2021-06-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-08-30
Results First Submit QC Date:
None
Results First Post Date:
2023-12-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-01
Last Update Post Date:
2023-12-22
Last Update Post Date Type:
ACTUAL